48-Week Data, Presented at the Digestive Disease Week (DDW) Meeting Today, Showed Clinical Benefit with Adacolumn® in a Sub-Group of Refractory Patients with Ulcerative Colitis
SAN DIEGO–(BUSINESS WIRE)– Data from the 48-week ART trial, presented today at the Digestive Disease Week (DDW) meeting, showed that remission and response rates were...